Compounded semaglutide

Description

Brand-name Ozempic (semaglutide) is available from IsraelPharm.  We can also supply a compounded version of semaglutide or the alternative (tirzepatide). Both require a healthcare provider’s prescription. Click here to learn moreabout compounded medications.  Semaglutide is the generic drug delivered in Ozempic (injectable) and Rybelsus (oral) diabetes control medications, and Wegovy (injectable) weight loss medication. Compounded semaglutide is made up individually for a patient in our pharmaceutical laboratories. Semaglutide is a glucagon-like peptide 1 (GLP-1) receptor agonist. GLP-1 is a hormone produced in the gut. It is released in response to food, prompting the release of insulin as well as a reduction in appetite. In the case of people with type 2 diabetes, it acts to slow digestion and so stimulates increased production of natural insulin. Semaglutide does not provide insulin from external sources (injection or oral insulin). For people who have been classified as overweight (with BMI between 27 and 30 plus associated medical conditions) or obese (with BMI greater than 30), semaglutide may be prescribed off-label as a weight-loss treatment along with appropriate diet controls and exercise. Read more about off-label prescribing here.